Poster Abstract Session:
169. Stewardship: Pediatric Antimicrobial Stewardship
Friday, October 6, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Epidemiology and Infection Control, Global ID, Pediatric ID, Trainee


Presentations:
Appropriateness of Antibiotic Prescribing in U. S. Children's Hospitals: A National Point Prevalence Survey
Alison Tribble, MD; Brian Lee, MPH, PhD; Lori Handy, MD, MSCE; Jeffrey S. Gerber, MD, PhD; Adam L. Hersh, MD, PhD; Matthew Kronman, MD, MSCE; Cindy Terrill, BS; Jason Newland, MD, MEd, FPIDS
Recurrent Antibiotic Prescriptions in the Kentucky Medicaid Population
Michael Smith, MD, MSCE; Navjyot Vidwan, MD; John Myers, PhD MSPH; Charles Woods, MD, MS, FIDSA, FSHEA, FPIDS
Impact of Patient Diagnoses and Provider Years of Practice on Antimicrobial Stewardship Program (ASP) Activities at a Non-freestanding Children’s Hospital
J. Michael Klatte, MD; Frank Szczerba, PharmD, BCPS; Alexander Knee, MS; Kathleen Kopcza, PharmD, BCPS; Evan Horton, PharmD; Donna Fisher, MD
Posters
  • 2017 IDWeek poster_final.pdf (637.3 kB)
  • Route of Administration for Highly Orally Bioavailable Antibiotics
    Michael Smith, MD, MSCE; Samir Shah, MD; Matthew Kronman, MD, MSCE; Sameer Patel, MD, MPH; Cary Thurm, PhD; Adam L. Hersh, MD, PhD
    Automated Metrics for Potential Adverse Outcomes in Pediatric Antimicrobial Stewardship
    Sameer Patel, MD, MPH; Caroline Reuter, MD; Rupal Patel, PharmD; Larry Kociolek, MD, MSCI; Roderick Jones, MPH
    Posters
  • Safety Metrics Poster.pdf (245.7 kB)
  • Perceptions among Pediatric Staff Nurses on Their Role and Confidence in Performing Antimicrobial Stewardship Activities
    Elizabeth Monsees, MSN, MBA, RN, CIC, FAPIC; Mary Anne Jackson, MD, FIDSA, FPIDS; Lori Popejoy, PhD, APRN, GCNS-BC, FAAN; Brian Lee, MPH, PhD; Jennifer Goldman, MD, MS
    Cefoxitin vs piperacillin/tazobactam for acute appendicitis in pediatric patients
    Hana Paek, PharmD; Hieu Pham, PharmD; Christina Gagliardo, MD; Patricia Caruso-Prendergast, PharmD
    Mycoplasma pneumoniae Macrolide Resistance in Children in Central Ohio Detected by Sequencing
    Mariana Lanata Piazzon, MD; Huanyu Wang, PhD; Kathy Everhart, B.S.; Octavio Ramilo, MD, FPIDS; Amy Leber, PhD
    Impact of Personalized Audit and Feedback on Management of Pediatric Outpatient Community-Acquired Pneumonia
    Lori Handy, MD, MSCE; Adriana Cadilla, MD; Lloyd Werk, MD, MPH; Maria Carmen Diaz, MD; James Franciosi, MD, MSCE; Joanne Dent, RN, MS, PMP; Jobayer Hossain, PhD; James Crutchfield Jr., PhD; Timothy Wysocki, PhD
    Posters
  • IDWeek Poster_Handy_1601.pdf (1.3 MB)
  • Adverse effects from antibiotics for acute respiratory tract infections in children: comparison of two data sources
    Jeffrey S. Gerber, MD, PhD; Rachael Ross, MPH; Matthew Bryan, PhD; A.Russell Localio, PhD; Theoklis Zaoutis, MD, MSCE; Richard Wasserman, MD; Alexander Fiks, MD, MSCE
    Impact of Multiplex Polymerase Chain Reaction Testing for Respiratory Pathogen Detection in Pediatric Patients 
    Courtney C. Sutton, PharmD, BCPPS; Patti J. Walton, MHSA, MT(ASCP); Montgomery F. Williams, PharmD, BCPS; Tracey L. Bastian, PharmD; Michael Wright, PharmD, BCPS, BCCCP; S. Shaefer Spires, MD
    Cost Analysis of an Antimicrobial Stewardship Program (ASP) Protocol for Adherence to the 2014 American Academy of Pediatrics (AAP) Palivizumab Prophylaxis Recommendations in a Freestanding Children’s Hospital 
    Andrea Green Hines, MD; Jennifer Zwiener, PharmD; Robin Stec, PharmD; Brenda Heybrock, RN, CIC; Lindsay Hegemann, BSN, RN, CPN; Kari Simonsen, MD, FIDSA, FPIDS
    Implementation of a Pragmatic Biomarker-Driven Algorithm to Guide Antibiotic Use in the Pediatric Intensive Care Unit: the Optimizing Antibiotic Strategies in Sepsis (OASIS) II Study
    Kevin Downes, MD; Emily Schriver, MS; Michael Russo, MD; Scott Weiss, MD, MSCE; Julie Fitzgerald, MD, PhD; Fran Balamuth, MD, PhD, MSCE; Pam Tolomeo, MPH; Warren Bilker, PhD; Jennifer Han, MD, MSCE; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA; Susan E. Coffin, MD, MPH, FSHEA, FPIDS; Jeffrey S. Gerber, MD, PhD
    Decreasing Vancomycin Utilization in the NICU by Optimizing Treatment Decisions in Suspected Late Onset Sepsis
    Diana Maffei, MD; Alpna Aggarwal, DO; Denise Riccobono, Pharm.D.; Lorry Rubin, MD, FIDSA; Annmarie Gennattasio, N.P.; Brianna Tarulli, R.N.; Linda Ranieri, R.N.; Karen Gee, R.N.; Barry Weinberger, M.D.
    Assessment of Surgical Antibiotic Prophylaxis in Pediatrics (ASAP-P)
    Juliana Lombardi, PharmD, MSc; Philippe Nguy, PharmD, MSc; Antoine Robichaud Ducharme, PharmD, MSc; Félix Thompson-Desormeaux, PharmD, MSc; Ni Nora Ruo, BPharm, MSc; Gabrielle Girard, BPharm, MSc; Mireille E Schnitzer, PhD; Daniel Thirion, PharmD, FCSHP; Jesse Papenburg, MD, MSc; Audrey-Anne Longpré, PharmD, MSc
    Short versus (vs) Prolonged Course of Therapy for Ventilator-associated Tracheitis (VAT) Caused by Non-lactose-fermenting Gram-negative Rods (NLFGNR) in the Pediatric Intensive Care Unit (PICU)
    Karen Fong, PharmD, AAHIVP; Robert Witcher, PharmD; Jennifer Lighter-Fisher, MD; John Papadopoulos, BS, PharmD, FCCM, BCCCP, BCNSP; Yanina Dubrovskaya, PharmD, BCPS (AQ-ID), AAHIVP
    Posters
  • VAT IDWeek Poster.pdf (873.2 kB)
  • Uncomplicated Urinary Tract Infection (UTI) in Ambulatory Primary Care Pediatrics. Are We Using Antibiotics Appropriately?
    Ban Al-Sayyed, MD; Jeremy Le, MD; Mohammad Mousbah Al-Tabbaa, MD; Brian Barnacle, MD Candidate; Jinma Ren, PhD; Meenakshy Aiyer, MD; Richard Tapping, PhD
    Posters
  • Ban ID Poster.ppt.pdf (815.4 kB)
  • Characteristics of Prospective Audit and Feedback in a Pediatric Cardiovascular Intensive Care Unit
    Laura Bio, PharmD, BCPS; Jenna Kruger, MPH; Betty Lee, PharmD; Hayden Schwenk, MD
    Posters
  • 1614_IDWKPOSTER_BIO.pdf (874.2 kB)
  • Improving Institutional Management of MSSA Infections in Children: A Quality Improvement Initiative
    Amol Purandare, MD; Madan Kumar, D.O.; Rana F. Hamdy, MD, MPH, MSCE
    Posters
  • IDWEEK17Poster_AP_RFH.pdf (243.3 kB)
  • CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.